Form 8-K Revance Therapeutics, For: Aug 08

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LEN
8. USO
9. LMT
10. TLT

Go back to Form 8-K Revance Therapeutics, For: Aug 08

Stifel Downgrades Revance Therapeutic (RVNC) to Hold Following Go Private Deal

August 12, 2024 10:07 AM EDT

Stifel analyst Annabel Samimy downgraded Revance Therapeutic (NASDAQ: RVNC) from Buy to Hold with a price target of $6.66 (from $20.00).

The analyst comments "Surprising to us, RVNC announced this morning its intention to merge with Crown Laboratories, a privately-held, global skincare company for... More